Press Release: Diabetomics : FDA issues Emergency Use Authorization for CovAb SARS-CoV-2 Ab Test, the oral fluid rapid test for SARS-CoV-2 antibodies

HILLSBORO, Ore., June 24, 2021 /PRNewswire/ -- Diabetomics, Inc., today announced the granting of an Emergency Use Authorization (EUA) by the US Food and Drug Administration for the Company's CovAb SARS-CoV-2 Ab point-of-care test. The product had also received a CE mark for marketing in...